Introduction
Febrile infection-related epilepsy syndrome (FIRES) is considered a severe epileptic encephalopathy with multifocal refractory status epilepticus. 1 In 1986 Awaya and Fukuyama first described an encephalitislike entity occurring in previously normal children. 2 Since then, the syndrome has been variably called severe refractory status epilepticus due to presumed encephalitis, 3 idiopathic catastrophic epileptic encephalopathy, 4 new-onset refractory status epilepticus, 5 devastating epileptic encephalopathy in school-aged children, 1 acute encephalitis with refractory repetitive partial seizures, 6 febrile infection-related epilepsy syndrome, 7 and fever-induced refractory epileptic encephalopathy in school-age children. 8 FIRES in previously healthy children is characterized by three phases: An initial phase with a simple febrile infection, a few days later followed by an acute phase with highly recurrent focal seizures that evolve rapidly into refractory status epilepticus often with no more fever and generally without additional neurological features, and finally a chronic phase consisting of drug-resistant epilepsy and neuropsychological impairment. 7 These symptoms occur mostly in children between 3 and 15 years of age, but adult patients have also been described. Series of patients with this particular epileptic encephalopathy have been published in Japan, the UK, France, Germany, Italy, the US, Austria, Singapore, and Taiwan. 1, [4] [5] [6] [7] [8] [9] [10] The etiology and the mechanisms underlying of FIRES are still unknown, and an immunologic source, 7,10-14 a genetic predisposition, and an inflammation-mediated process 11 have been hypothesized. Currently, the ketogenic diet may be considered as an efficacious treatment. 8 Here, we analyze the electroclinical features, neuroimaging findings, treatment, and outcome of 12 patients with FIRES.
Methods
This is a retrospective study conducted at the Garrahan Hospital of Buenos Aires of 12 children with FIRES seen between 1997 and Seizure 22 (2013) [553] [554] [555] [556] [557] [558] [559] 2012. We evaluated the charts of these patients with a mean time of follow-up of 6.5 years (range, 1-15 years).
The inclusion criteria were the following: Previously healthy children between 2 and 16 years of age with normal psychomotor development, acute onset of refractory seizures associated with an encephalitis-like illness; no infectious pathogen found on testing of cerebrospinal fluid (CSF), serum, or other body fluids; and evolution to chronic epilepsy without an anticonvulsant-free latent period. 8 The status was considered refractory if it failed to respond to initial antiepilepic drug treatment (intravenous benzodiazepines, phenytoin, phenobarbital, as well as valproic acid and levetiracetam).
Patients with a similar presentation due to viral encephalitis, acute disseminated encephalomyelitis, Rasmussen encephalitis, structural brain abnormalities, or metabolic disorders were excluded.
Based on the medical records we evaluated personal antecedents, family history, and clinical details including seizure semiology and management in the acute period. Virological, immunological, metabolic, and genetic investigations were studied. Neuropsychological assessments as well as clinical features and management of the chronic epilepsy were also analyzed.
All patients had CSF, blood, and other body fluids tested for infective pathogens. In all cases markers of inflammation in CSF and blood were investigated. Different antibody and metabolic tests were performed. Genetic testing and brain biopsy were not performed in any of the patients.
All interictal and ictal EEG recordings, computerized tomography (CT) scans, and magnetic resonance imaging (MRI) performed in both the acute and chronic phases were analyzed. Six and four patients had video-EEG recordings in the acute and chronic phases, respectively. All patients underwent MRI study at 1.5 T in the acute period and in the chronic phase, and three of them at 3 T with an epilepsy protocol in the chronic period. Positron emission tomography scans were not done in any of the patients in either acute or chronic phases.
In the chronic phase, we analyzed the electroclinical features, treatment, and evolution. Behavior was assessed by parental report. The neuropsychological evaluation included standardized tests of intellectual abilities in all patients.
Results

General features
We included 12 patients, eight males and four females. All were previously well, with a normal development. No patients had remarkable personal antecedents or a past history of seizures. One patient had a family history of febrile seizures and another had a family history of epilepsy.
Clinical and EEG presentation
The children had a mean and median age at presentation of 8.5 and 10 years (range, 2-13.5 years), respectively. Upper respiratory tract infection and gastroenteritis, both associated with fever, were observed in nine and three patients, respectively. Clinical encephalitis-like features characterized by fever, headache, drowsiness, and confusion preceded the onset of seizures by 2-10 days.
In the acute phase, the seizures were focal with loss of consciousness in all children, and with secondary generalization characterized by bilateral clonic seizures in three. Autonomic manifestations, such as pallor, apnea, and cyanosis, were registered in eight patients. Three patients also had apparently generalized seizures. The seizures rapidly increased in frequency (28-102 seizures daily) and exacerbated into status epilepticus within 24-36 h. One patient had repetitive facial myoclonias. The duration of intensive care treatment was 2-40 days (median 16 days).
Interictal EEG recordings showed diffuse delta-theta background slowing was seen in all cases. The initial ictal EEG recordings showed a temporal seizure onset in four children (33%), frontotemporal in four (33%), frontal in two (16.5%), and frontoparietal in two children (16.5%) (Fig. 1) . All of them rapidly developed multifocal and independent seizures, unilateral or bilateral, that propagated to the same hemisphere in three and to the contralateral hemisphere in nine involving different lobes.
Investigations
All the patients underwent CSF study and pleocytosis was found in seven (58.2%). CSF protein was elevated in one patient. AntiNMDARantibodies were negative in two patients, and detection of oligoclonal bands in CSF was performed in six patients. All evaluations were negative, except that oligoclonal bands in CSF were found in two of six patients.
Magnetic resonance imaging (MRI) was performed in all cases. The initial MRI was normal in five patients of 12. The abnormalities found in the remaining seven patients were signal hyperintensities in both hippocampi in five patients ( Fig. 2A) . In three of them, the periinsular region was also affected. Hyperintensity in the basal ganglia was detected in one case (Fig. 2C) . The follow-up MRI revealed generalized atrophy in four ( Fig. 2B ) and signal hyperintensity in four other patients. The signal hyperintensity was located in both hippocampi in three and in the periinsular region in one.
Treatment
All patients were treated with acyclovir and/or antibiotics to cover the possibility of central nervous system infections for two weeks or until positive results were ruled out. All patients received multiple antiepileptic schemes, including phenobarbital (12), phenytoin (12) , benzodiazepines (12) , levetiracetam (12) , sodium valproate (6), thiopentone (6), carbamazepine (5), oxcarbazepine (4) , and topiramate (6) with a negative response. Eight patients were treated with barbiturates at doses sufficient to induce burstsuppression on the EEG. Five of them responded well temporarily. Thus, barbiturates were effective in stopping the status epilepticus in these five patients.
Ten patients received three times 1.2 g intravenous immunoglobulin (IVIG) every 10 and 14 days, except three cases who received IVIG every 21 days over 4, 6, and 8 months, respectively, and nine patients received steroids in different forms and doses. Most of them received a pulse of methyl prednisolone at 30 mg/ kg/day over 5 days followed by oral prednisone at 1 mg/kg/day. Two patients treated with IVIG and one patient given steroids had a good response, but the response was sustained in only one treated with IVIG with 50% seizure reduction.
Two patients were treated with a ketogenic diet in the acute phase, of whom one showed a good and sustained response with a 50-75% seizure reduction. The remaining patient had a seizure reduction of less than 50%. One patient did not respond well to plasmapheresis. One patient had a partial response (a seizure reduction of approximately 50%) to two doses of rituximab, however, the treatment was withdrawn due to marked lymphopenia. 
Outcome
All patients had epilepsy and there was no prolonged period of time without seizures between the acute and the chronic phase. Two patients became seizure free after 18 and 25 months of antiepileptic treatment, respectively. The other 10 patients have refractory epilepsy. All patients had simple or complex focal seizures. Seizure semiology, based on parents' report in all patients and video-EEG recording in four patients, revealed head-and-eyeversion episodes in four cases, unilateral tonic and clonic seizures in two, and unilateral orofacial clonic seizures in one. Dystonic posturing was observed in two patients and autonomic manifestations in two other cases. Behavioral arrest and loss of consciousness associated with automatisms occurred in seven patients, three of whom had an abdominal aura. Four of 12 patients had secondary generalized tonic or tonic-clonic seizures. In two patients the seizures had a multifocal origin. Focal status epilepticus occurred in three patients requiring admissions to the intensive care unit. The seizures occurred daily in two cases, weekly in one patient, monthly in four, and every 2-4 months in the remaining patients. The seizures occurred in clusters in five patients. All patients had seizures while awake and four of them also during sleep.
Ten patients currently receive two to three AEDs. Two of 12 patients are seizure free after 2 and 10 years of follow-up. Two patients continue on a ketogenic diet. They have brief seizures every 2 and every 4 months, respectively. Three patients continue receiving IVIG without good results. Surgery was performed in one patient with refractory temporal lobe epilepsy secondary to mesial sclerosis; she has a 50% seizure reduction after 2 years of followup. In one patient with refractory seizures and frequent episodes of status epilepticus, a vagus nerve stimulator has recently been implanted.
The background interictal EEG recordings showed slow-wave activity in all patients. Bilateral and focal slow waves mainly in frontotemporal regions were also observed in ten of 12 patients. All patients had focal spikes predominantly in temporal, frontal, and frontotemporal lobes. Sharp waves and spike waves were registered in five and three patients, respectively. Bilateral and synchronous discharges were recorded in two patients. Generalized paroxysms and focal or generalized fast rhythms were not registered. EEG abnormalities were activated during sleep in five patients. No changes were observed during the hyperventilation.
The ictal EEG showed rhythmic theta-delta followed by fast rhythms in six cases. Ictal discharges were characterized by rhythmic theta-delta activities followed by rhythmic spikes and spike-wave discharges in four cases (Fig. 3) . Fast activity followed by slow activity that increased in voltage and frequency was seen in two other cases. The ictal EEG manifestations were focal in six, multifocal unilateral in three, and multifocal and bilateral in the remaining three patients.
During the chronic epilepsy period the MRI showed mild diffuse cortical atrophy in three patients and severe diffuse cortical atrophy in two. Two patients had unilateral mesial temporal sclerosis and two had bilateral mesial temporal sclerosis.
In Table 1 , the electroclinical features, investigations, imaging findings, treatment, and outcome of the patients in our series are shown.
Discussion
Our series of patients supports that FIRES is a severe epileptic encephalopathy subsequent to a febrile event. To our knowledge, these are the first patients with this particular epileptic syndrome described in South America. The age at onset of the syndrome was in pre-school or school years. The clinical manifestations of the children in this study are very similar to those of other series of patients recently published. 5, 6, 8, 12 In our patients as in the other series, barbiturates at high doses to induce burst-suppression coma were the main effective treatment to temporarily stop the seizures in the acute phase. 12 Despite their secondary risks, they may be considered the best option to end the seizures in the acute period. 8 Two of our cases responded well to a ketogenic diet in the acute phase of FIRES similar to the cases reported by Mikaeloff et al. 1 and Nabbout et al. 8 Another patient responded well to IVIG, as did two patients with FIRES published by Specchio et al. 14 One patient in our series received rituximab with a partial response, however, the drug had to be withdrawn due to adverse events. The first experience with rituximab was reported by Howell et al. 12 without good results.
The same group was also the first to use vagus nerve stimulation for the treatment of patients with FIRES in the acute phase. 12 Many other patients were treated with various agents in the acute phase, including propofol, lidocaine, ketamine, verapamil, and plasmapheresis, with no positive response. 8 Nevertheless, immunotherapies, including plasma exchange, are reported to be of benefit not only in the acute but also in the chronic phase in rare cases. 8, 12, 14 Considering the development into chronic epilepsy, it is interesting to analyze the electroclinical features, treatment, and evolution of patients with FIRES. One question is whether to divide the syndrome into two phases (acute and chronic) or whether to consider it as a single process that starts with a dramatic electroclinical event that in most of the patients continues with seizures without a silent period. None of our cases had a seizure-free period, similar to other series of patients published. 12 Moreover, the fact that the seizures have the same electroclinical features in both periods supports the hypothesis that FIRES consists of a single pathological event. The electroclinical findings of our series of patients as well as those of other patients published are very similar, suggesting a well-defined epileptic syndrome. It is characterized by refractory simple or focal seizures very often without secondary generalization. Autonomic seizures are frequent. The ictal EEGs show that the seizures are focal or multifocal arising independently from one or both hemispheres with similar electroencephalographic features. The facial and limb focal motor manifestations and the ictal EEG findings suggest that they may have a neocortical frontal lobe origin. 6, 9, 13 Mesial temporal sclerosis was considered the cause of the refractoriness of the seizures of these patients with FIRES. 1 However, our case with refractory seizures and mesial temporal sclerosis who underwent surgery continued with seizures, and thus we believe that the epileptogenic zone may also involve the periinsular or other frontal lobe regions. To our knowledge, ours is the first patient with FIRES who received surgical treatment.
In the chronic phase, no AEDs were reported as beneficial in the treatment of patients with FIRES, despite different schemes. Other therapeutic alternatives may be considered, such as steroids, IVIG, the ketogenic diet, vagus nerve stimulation, and surgery. 1, 6, 9, [13] [14] [15] In our present series of patients, two cases had a good outcome. Similar exceptional cases have been published by Kramer et al. 9 Therefore, we may consider that the course of the disease is severe most patients, but that some patients may have a relatively better outcome. These patients could suggest that the clinical spectrum of FIRES may be broader. FIRES is considered to have an immune-mediated or inflammatory basis, taking into account the absence of an infective cause. However, patients with a similar course associated with infectious agents have been described. 7 The two phases described in patients with FIRES suggest a possible infection-triggered process rather than an infectious entity. Thus, since most of the patients had seizures immediately following a febrile episode, an autoimmune mechanism could be considered. In the literature, the association of epilepsy and an autoimmune process has been reported in neurologic diseases. [15] [16] [17] [18] [19] [20] [21] [22] Different antibodies have been investigated in patients with FIRES with negative results. 3, [16] [17] [18] [19] [20] [21] [22] Nevertheless, studies in patients with a similar entity positive antibodies, such as anti-GAD antibodies, anti-GluR3 antibodies, and antibodies against GluRepsilon 2, have been detected. 6, 9 These autoantibodies have previously been found in patients with epilepsy, but not specifically in cases with FIRES. It has been postulated that these findings may represent a secondary phenomenon rather than the primary pathogenic mechanism. 20 Although an autoimmune mechanism may be the main pathogenic process in a subgroup of these patients, up to now there no evidence to support that autoantibodies are the etiology of FIRES. Environmental factors, such as fever or an unidentified infectious agent may also trigger the clinical expression of the underlying epileptic predisposition. A similar phenomenon has been shown in, for example, Dravet syndrome and migrating focal seizures in infancy. 13, [23] [24] [25] [26] A FIRES-like syndrome associated with refractory status epilepticus may be due to PCDH19 mutations in girls. 27 These findings may lead us to investigate a genetic origin in patients with FIRES. Considering the good response to the ketogenic diet, some patients with FIRES may be considered to have another clinical phenotype of a glucose transporter defect.
14 Prospective, collaborative, and multicenter studies in patients with electroclinical features compatible with FIRES would be necessary to further investigate the probable etiology, pathogenesis, treatment, and outcome, and to define its nosological place. Furthermore, it would be important to create an international consensus group to define a treatment protocol to improve the management of patients with this severe entity.
Conclusion
FIRES is a well-defined severe epileptic syndrome, probably in the group of epileptic encephalopathies, characterized by focal or multifocal seizures arising from the neocortical regions with an as yet unknown etiology.
The course of our series of patients was generally severe, with seizures refractory to different therapeutic options, and associated with mental retardation and behavioral disturbances. Two of them had a good outcome.
In the acute phase, the status epilepticus was stopped with high doses of barbiturates in five patients. The ketogenic diet was useful in two patients, one of whom maintained a good response, and another patient responded well to IVIG. In the chronic phase, IVIG, the ketogenic diet, and surgery may be considered.
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